270 Results for "

nanomolar

" in MedChemExpress (MCE) Product Catalog:
Products (270)

270 Results for "nanomolar" in MCE Product Catalog:

58
58 Publications Verification
Cat. No.: HY-134813
CAS No.: 2621928-55-8
Purity:  99.97%
Target:  

Ras

Research Areas:  

Cancer

MRTX1133 is a noncovalent, potent, and selective alkyne-based KRAS G12D inhibitor. MRTX1133 optimally fills the switch II pocket and extends three substituents to favorably interact with the protein, resulting in an estimated KD against KRAS G12D of 0.2 pM. MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex, thereby inhibiting mutant KRAS-dependent signal transduction. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells. MRTX1133 has single digit nanomolar activity in cellular assays and marked in vivo efficacy in tumor models harboring KRAS G12D mutations .
loading...
    loading...
52
52 Cited Publications
Cat. No.: HY-141520
CAS No.: 2603528-97-6
Purity:  99.75%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

ART558 is a potent, selective and allosteric DNA polymerase theta (Polθ) inhibitor (IC50=7.9 nM). ART558 elicits BRCA-gene synthetic lethality and DNA damage. ART558 can be used for the research of cancer, such as breast cancer .
loading...
    loading...
35
35 Cited Publications
Cat. No.: HY-136927
CAS No.: 129425-81-6
Purity:  99.81%
Target:  

STING

Research Areas:  

Inflammation/Immunology Cancer

MSA-2, a potent and orally available non-nucleotide STING agonist, is bound to STING as a noncovalent dimer with nanomolar affinity. MSA-2 shows EC50s of 8.3 and 24 μM for human STING isoforms WT and HAQ, respectively. MSA-2 stimulates interferon-β secretion in tumors, induces tumor regression with durable antitumor immunity, and synergizes with anti-PD-1 in syngeneic mouse tumor models .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-114361
CAS No.: 2260791-14-6
Purity:  99.69%
Target:  

OGT Acyltransferase

Research Areas:  

Metabolic Disease

OSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor, with an EC50 of 3 μM in cells.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12866
CAS No.: 1223403-58-4
Purity:  99.95%
Synonyms: LOXO-101; ARRY-470
Target:  

Trk Receptor Apoptosis

Research Areas:  

Cancer

Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12866A
CAS No.: 1223405-08-0
Purity:  98.96%
Synonyms: LOXO-101 sulfate; ARRY-470 sulfate
Target:  

Trk Receptor Apoptosis

Research Areas:  

Cancer

Larotrectinib sulfate (LOXO-101 sulfate; ARRY-470 sulfate) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928
CAS No.: 1352608-82-2
Synonyms: EW-7197; TEW-7197
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib (EW-7197) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib has potently antimetastatic activity and anticancer effect .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928A
CAS No.: 1352610-25-3
Synonyms: EW-7197 Hydrochloride; TEW-7197 Hydrochloride
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib Hydrochloride also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib Hydrochloride has potently antimetastatic activity and anticancer effect .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-14776
CAS No.: 865311-47-3
Purity:  99.87%
Synonyms: CX-3543
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

Quarfloxin (CX-3543), a fluoroquinolone derivative with antineoplastic activity, targets and inhibits RNA pol I activity, with IC50 values in the nanomolar range in neuroblastoma cells. Quarfloxin disrupts the interaction between the nucleolin protein and a G-quadruplex DNA structure in the ribosomal DNA (rDNA) template .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-16978
CAS No.: 1415716-58-3
TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against only EP2, >300-fold selectivity over human EP3, EP4, and IP receptors, 100-fold selectivity over EP1 receptors .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-50001
CAS No.: 341001-38-5
Target:  

Influenza Virus

Research Areas:  

Infection

Nucleozin, a potent inhibitor of influenza A virus infection, induces the formation of nucleoprotein (NP) aggregates and antagonizes its nuclear accumulation, leading to cessation of viral replication. Nucleozin impedes influenza A virus replication in vitro with a nanomolar EC50 .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-12513
CAS No.: 1386874-06-1
Purity:  99.27%
Synonyms: LY3023414
Target:  

PI3K DNA-PK mTOR Autophagy

Research Areas:  

Cancer

Samotolisib (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. Samotolisib potently inhibits mTORC1/2 at low nanomolar concentrations .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-104042
CAS No.: 1644545-52-7
Purity:  99.87%
Synonyms: AG-881
Research Areas:  

Cancer

Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K. Vorasidenib can be used for the study of grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1/2 mutation .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-12583
CAS No.: 1527503-11-2
Purity:  98.01%
A-366, a chemical probe, is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC50s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC50=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (Ki=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101213
CAS No.: 145075-81-6
Purity:  98.84%
OSW-1, isolated from Ornithogalum caudatum, is a specific antagonist of ooxysterol binding protein (OSBP) and OSBP-related protein 4 (ORP4) with GI50s in the nanomolar range in human cancer lines.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-122575
CAS No.: 4431-00-9
Purity:  ≥92.0%
Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively . Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase . Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis . Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway . Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 μM . Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 µM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-131904
CAS No.: 2004714-34-3
Purity:  99.54%
Target:  

Enolase Apoptosis

Research Areas:  

Metabolic Disease Cancer

POMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-16787
CAS No.: 313254-51-2
Target:  

Sodium Channel

Research Areas:  

Cardiovascular Disease

ICA-121431 is a nanomolar potent and broad-spectrum voltage-gated sodium channel (Nav) blocker, shows equipotent selectivity for human Nav1.1 and Nav1.3 subtypes with IC50 values of 13 nM and 23 nM, respectively. ICA-121431 shows less potent inhibition of Nav1.2 (IC50=240 nM) and 1,000 fold selectivity against Nav1.4, Nav1.6, and the TTX-resistant human Nav1.5 and Nav1.8 channels (IC50s >10 μM).
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-114388
CAS No.: 2093421-02-2
Purity:  99.48%
Research Areas:  

Inflammation/Immunology

QM385 is a potent sepiapterin reductase (SPR) inhibitor with an IC50 of 1.49 nM, which blocks T-cell proliferation and autoimmunity at nanomolar potency and with good oral bioavailability .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-102074
CAS No.: 1374006-96-8
Purity:  99.90%
Target:  

Measles Virus

Research Areas:  

Infection

ERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus). ERDRP-0519 inhibits morbilliviruses with nanomolar potency. .
loading...
    loading...